William D. Turner, Chief Regulatory Officer at Vera Therapeutics, Inc. (VERA), sold 2,187 shares at $41.98 ($92K) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Open-market sale of $92k VERA by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERA | SELL | 2025-12-04 | $400K | — | Filing → |
| SRRA | SELL | 2022-04-07 | $477K | — | Filing → |
| SRRA | SELL | 2022-03-22 | $4K | — | Filing → |